-
Mashup Score: 0A plain language summary of the PERSEUS study: daratumumab + VRd treatment options for newly diagnosed multiple myeloma - 2 month(s) ago
Our partner journal Future Oncology has published a Plain language summary of publication describing the first analysis of the PERSEUS study.
Source: www.oncology-central.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0A journey through value-based oncology care - 8 month(s) ago
What challenges are associated with value-based oncology care and how can these be overcome?
Source: www.oncology-central.comCategories: General Medicine News, Onc News and JournalsTweet-
What challenges are associated with value-based oncology care and how can these be overcome? Read out latest interview feature to find out >>> https://t.co/4FXRho5x9i
-
-
Mashup Score: 0Frontiers in brain tumor research and empowering women in STEM - 9 month(s) ago
Discover the strides being made to unravel the complexities of brain tumors in our latest interview with Karen Noble.
Source: www.oncology-central.comCategories: General Medicine News, Onc News and JournalsTweet-
Discover the strides being made to unravel the complexities of brain tumors in our interview with Karen Noble from @braintumourrsch https://t.co/Pvs9R0pset #IWD24
-
-
Mashup Score: 0A journey through value-based oncology care - 9 month(s) ago
What challenges are associated with value-based oncology care and how can these be overcome?
Source: www.oncology-central.comCategories: General Medicine News, Onc News and JournalsTweet-
How could #AI and value-based care can influence healthcare delivery help create better care journeys? Find out in our latest interview >>> https://t.co/Pw6GjEzfAx
-
-
Mashup Score: 0Championing diversity and inclusion in neuro-oncology - 9 month(s) ago
Explore opportunities for women in neuro-oncology with Dr Macarena Ines De La Fuente who has been the co-chair of the SNO’s Women and Diversity Committee.
Source: www.oncology-central.comCategories: General Medicine News, Onc News and JournalsTweet-
Explore opportunities for women in neuro-oncology, with insights from @SylvesterCancer's Macarena de la Fuente, who has been the co-chair of the Society for Neuro-Oncology’s Women and Diversity Committee: https://t.co/MUTIroqEpz @NeuroOnc
-
-
Mashup Score: 0
How can MRI-guided radiation therapy offer in terms of real-time insights into glioblastoma disease progression?
Source: www.oncology-central.comCategories: General Medicine News, Onc News and JournalsTweet-
Radka Stoyanova @SylvesterCancer is using AI to both detect glioblastoma tumor volume changes and build models to predict the response of a patient to a particular treatment. https://t.co/dQdRQ5kARo
-
-
Mashup Score: 0A journey through value-based oncology care - 9 month(s) ago
What challenges are associated with value-based oncology care and how can these be overcome?
Source: www.oncology-central.comCategories: General Medicine News, Onc News and JournalsTweet-
From data infrastructure to patient empowerment, learn about the multifaceted approach to overcoming hurdles in value-based oncology care >>> https://t.co/YKFzr0ull5
-
-
Mashup Score: 0The Phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions - 9 month(s) ago
eNRGy is a clinical trial of zenocutuzumab for cancer caused by NRG1 gene fusions. Find out more in our latest journal feature here.
Source: www.oncology-central.comCategories: General Medicine News, Onc News and JournalsTweet-
eNRGy is a global Phase I/II trial currently recruiting patients with NRG1+ NSCLC, PDAC, or other solid tumors to assess zenocutuzumab, an investigational bispecific IgG1 antibody that inhibits NRG1-activated HER2/HER3 oncogenic signaling https://t.co/Cv1tfaJsq7
-
-
Mashup Score: 0Navigating opportunities and challenges in pancreatic cancer: an interview with Mandana Kamgar - 9 month(s) ago
What are the latest developments in diagnostic and therapeutic options for pancreatic cancer patients? Find out in our interview with Mandana Kamgar
Source: www.oncology-central.comCategories: General Medicine News, Onc News and JournalsTweet-
What are the latest developments in diagnostic and therapeutic options for #PancreaticCancer patients? Find out in our interview with Mandana Kamgar (@MedicalCollege) https://t.co/tKvlyHbSzJ #IWD2024 #InspireInclusion
-
-
Mashup Score: 0The Phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions - 9 month(s) ago
eNRGy is a clinical trial of zenocutuzumab for cancer caused by NRG1 gene fusions. Find out more in our latest journal feature here.
Source: www.oncology-central.comCategories: General Medicine News, Onc News and JournalsTweet-
Learn more about the eNRGy Phase I/II trial, a study investigating zenocutuzumab administered to patients with cancer caused by NRG1 gene fusions >>> https://t.co/nQ35Fbmdfz @Future_OncolFSG
-
Read about the PERSEUS trial in a format that can be easily shared with multiple myeloma patients and their caregivers >>> https://t.co/dMwKW8qNwP @phoebejoyho1 @myelomaoslo @AnnaSureda5 @paurotero @IMFmyeloma @HealthTree @LLSusa @SparksCures https://t.co/4XLfaKshGP